Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy

Cell Research

Volumn 24, Issue 8, 2014, Pages 977-993

  Li, Jun ^a,b   Qi, Man ^a   Li, Changming ^a   Shi, Dan ^a,b   Zhang, Dasheng ^a,b   Xie, Duanyang ^a   Yuan, Tianyou ^a,b   Feng, Jing ^a   Liu, Yi ^a,b   Liang, Dandan ^a,b   Xu, Xinran ^a,b   Chen, Jinjin ^a   Xu, Liang ^a,b   Zhang, Hong ^a,b   Ye, Jiangchuan ^a   Lv, Fei ^a   Huang, Jian ^a   Peng, Luying ^a   Chen, Yi Han ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

optic atrophy 1; oxidative stress; pathological cardiac hypertrophy; translocases of mitochondrial outer membrane

Indexed keywords

CARRIER PROTEIN; SMALL INTERFERING RNA; TOMM70A PROTEIN, HUMAN;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIOMEGALY; CYTOLOGY; DISEASE MODEL; DOWN REGULATION; GENETICS; HEART FAILURE; HEART MUSCLE CELL; HUMAN; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; RAT; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; ZEBRA FISH;

ANIMALS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HEART FAILURE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, SMALL INTERFERING; ZEBRAFISH;

EID: 84905575123     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2014.94     Document Type: Article

References (32)

1. WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2013; 128:e240-e319.
2. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003; 348:2007-2018.
3. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 2004; 109:1580-1589.
4. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003; 65:45-79.
5. Abel ED, Doenst T. Mitochondrial adaptations to physiological vs pathological cardiac hypertrophy. Cardiovasc Res 2011; 90:234-242.
6. Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol 2013; 55:31-41.
7. Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 2010; 11:655-667.
8. Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell 2009; 138:628-644.
9. Joseph AM, Ljubicic V, Adhihetty PJ, Hood DA. Biogenesis of the mitochondrial Tom40 channel in skeletal muscle from aged animals and its adaptability to chronic contractile activity. Am J Physiol Cell Physiol 2010; 298:C1308-C1314.
10. Colavecchia M, Christie LN, Kanwar YS, Hood DA. Functional consequences of thyroid hormone-induced changes in the mitochondrial protein import pathway. Am J Physiol Endocrinol Metab 2003; 284:E29-E35.
11. Schmidt O, Harbauer AB, Rao S, et al. Regulation of mitochondrial protein import by cytosolic kinases. Cell 2011; 144:227-239.
12. Grimm D, Elsner D, Schunkert H, et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 1998; 37:91-100.
13. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982; 51:787-801.
14. Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res 2011; 91:279-288.
15. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007; 93:903-907.
16. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2013; 7:589-600.
17. van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 2013; 123:37-45.
18. Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007; 49:241-248.
19. Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89:799-845.
20. Young JC, Hoogenraad NJ, Hartl FU. Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 2003; 112:41-50.
21. Suzuki H, Maeda M, Mihara K. Characterization of rat TOM70 as a receptor of the preprotein translocase of the mitochondrial outer membrane. J Cell Sci 2002; 115:1895-1905.
22. Curado S, Ober EA, Walsh S, et al. The mitochondrial import gene tomm22 is specifically required for hepatocyte survival and provides a liver regeneration model. Dis Model Mech 2010; 3:486-95.
23. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012; 337:1062-1065.
24. Piquereau J, Caffin F, Novotova M, et al. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc Res 2012; 94:408-417.
25. Duvezin-Caubet S, Jagasia R, Wagener J, et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 2006; 281:37972-37979.
26. Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 2001; 37:676-685.
27. Ramonet D, Perier C, Recasens A, et al. Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency. Cell Death Differ 2013; 20:77-85.
28. Ishihara N, Fujita Y, Oka T, et al. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 2006; 25:2966-2977.
29. Kato H, Lu Q, Rapaport D, et al. Tom70 is essential for PINK1 import into mitochondria. PLoS ONE 2013; 8:e58435.
30. Vincow ES, Merrihew G, Thomas RE, et al. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci USA 2013; 110:6400-6405.
31. Arany Z, Novikov M, Chin S, et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci USA 2006; 103:10086-10091.
32. Westerfield M. The zebrafish book: A guide for the laboratory use of zebrafish (Danio rerio). Eugene, University of Oregon Press. Paperback 2007.